Min Hee Hong

51PUBLICATIONS

286CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (51)

Sort by Publication Date:

|Jul 13, 2026

A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Jul 03, 2026

EpCAM<sup>+</sup> Extracellular Vesicle PD-L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response.

|May 13, 2026

BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|Apr 20, 2026

A Phase 2 Study of Stereotactic Ablative Radiotherapy Plus Atezolizumab Plus Tiragolumab in Treatment-naïve Patients with Advanced Non-small Cell Lung Cancer.

|Feb 06, 2026

JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.

Eun Ji Lee, Ji Ae Ko, Min-Je Kim

|Dec 25, 2025

Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29).

Min Hee Hong, Sung Kwan Shin, Su-Jin Choi

Pageof 9

Frequent Collaborators

12 joint publications

Hye Ryun Kim

11 joint publications

Byoung Chul Cho

Sun Min Lim

Seok-Young Kim

Kyoung-Ho Pyo

Dong Kwon Kim

Jii Bum Lee

Eun Ji Lee

Insuk Lee

Beung-Chul Ahn

Frequent Collaborators

12 joint publications

Hye Ryun Kim

11 joint publications

Byoung Chul Cho

8 joint publications

Sun Min Lim

8 joint publications

Seok-Young Kim